Using Diagnostic Tools to Stage Breast Cancer

Running, not enrolling · Not applicable

Conditions studied: Breast Cancer

In brief

This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.

Key facts

Study ID

NCT00367666

Run by

University of Pennsylvania

People needed

400

Starts

2002-03-01

Expected to finish

2027-03-12

Last updated by the study team

2026-03-10

Who can join

Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women recently diagnosed with Breast Cancer
• Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania

You may not qualify if…

• Contraindications to MRI
• previously diagnosed with breast cancer (in the smae breast) within the past 5 years
• Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy.
• Pregnant women

Where it is running

• University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.